Addiction Institute at Mount Sinai

Current Studies

Current Studies

Our research efforts are comprehensive in scope, using integrated research strategies across multiple disciplines including brain imaging, genomics, public health, and clinical trials with pharmacological agents and behavioral interventions. These studies include:

  • Clinical Studies (see below)

Active Projects include:

Outpatient Clinical Studies 




Acute and Short-Term Effects of CBD Administration on Cue-Induced Craving in Heroin-Dependent Drug-Abstinent Humans


BupeCare Platform for Enhanced Buprenorphine Treatment (MedicaSafe)


NIDA CTN protocol 006 - Implementation of ED-initiated Buprenorphine for Opioid Use Disorder


A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study of Outpatients with Opioid Dependence Transitioned from 8 mg or Less of Sublingual Buprenorphine or Buprenorphine/Naloxone to Four Probuphine® Subdermal Implants


Prevention of Cardiovascular Medical Consequences of Drug Overdose


Using event-related potentials to longitudinally track cue-induced craving incubation in cocaine addicted individuals


Endothelial Dysfunction Markers in Cocaine-Dependent Patients Under Recent Abstinence


NIAAA NCIG-006: Randomized, Double-Blind, Placebo-Controlled Trial Of The Safety And Efficacy Of Horizant® (Gabapentin Enacarbil) Extended-Release Tablets For The Treatment Of Alcohol Use Disorder



Inpatient Clinical Studies 




Synthetic Cannabinoid Use in Relation to Psychosis: Evaluation of Stress, Immune Function, and Genetics


Prevalence of Pain and Illicit Substance Use, as well as Attitudes Towards Medical Cannabinoids among Surgical Patients at the Mount Sinai Hospital



Neuroimaging Studies

Neuropsychoimaging of Addiction and Related Conditions

Neurocircuitry of Impaired insight in addiction

Effects of Early Life Stress on Brain Dysfunction in HIV+ Adults: An fMRI Study



Epidemiology Studies

DRIVE (Drug use and blood-borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic among People who Inject Drugs in Haiphong, Vietnam

Combined Prevention to Reduce Initiation into Injecting Drug Use

Risk Factors for AIDS among Drug Users: Getting Close to Zero

Evaluating ART for all HIV Seropositives: Can it work in the Hardest Cases?